Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patients

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · New England Journal of Medicine · 2016 · 1.2K citations · Full text

Medicine, Dermatology, Oncology +17

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid et al. · The Lancet Oncology · 2016 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +11

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Omid Hamid, Caroline Robert, Adil Daud et al. · Annals of Oncology · 2019 · 944 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features

Michelle Heath, Natalia Jaimes, Bianca D. Lemos et al. · Journal of the American Academy of Dermatology · 2008 · 919 citations · Full text

Veterinary Medicine, Oncology, Pathology +11